Plain-English translation of NCT07515638 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Rheumatoid Arthritis research guide →The Immun4Cure Cohort is a long-term research study designed to help scientists better understand three serious autoimmune diseases: rheumatoid arthritis, systemic lupus erythematosus (lupus), and systemic sclerosis (scleroderma). Researchers will collect blood, urine, and other biological samples from people living with these conditions, as well as from healthy volunteers, and follow them over 5 years to identify patterns that could lead to better treatments and earlier diagnosis.
These three autoimmune diseases are complex and affect many people worldwide, causing chronic pain, inflammation, and tissue damage. By studying the immune systems of affected individuals alongside healthy people, researchers hope to discover what goes wrong in these diseases and develop more targeted, effective treatments.
You likely qualify if…
You likely don't qualify if…
If you join, you'll visit the hospital at baseline and then regularly over 5 years for clinical check-ups and sample collection. You'll donate blood, urine, saliva, and stool samples, and researchers may ask about your environment and medical history. If you're a healthy volunteer, you'll have visits at the start and again at 12 months. Some participants may be asked to provide optional tissue biopsies. The study does not involve taking an experimental medication—it focuses on gathering biological information to help future patients.
AI-generated summary from trial data · Jul 7, 2026 · Not medical advice
France
Sponsor
University Hospital, Montpellier
Enrollment target
~500 participants
Started
June 2026
Primary completion
June 2031
Age range
18 Years and older
Last updated on clinicaltrials.gov in June 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Charlotte KAAN
University Hospital, Montpellier
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.